(26 days)
No
The document explicitly states that the modification does not alter the fundamental scientific technology of the predicate device and there are no mentions of AI, ML, or related concepts. The changes are limited to the physical stand.
Yes
The device is a neonatal incubator indicated for thermoregulation and controlling oxygen and humidity for infants, which are therapeutic functions to support infant health.
No
The device is a neonatal incubator for thermoregulation and environmental control, not for identifying a disease or condition.
No
The device description explicitly states it is a neonatal incubator, which is a physical hardware device. The modification described is the replacement of a physical trolley. There is no mention of the device being solely software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants." This describes a device used to maintain a controlled environment for a patient, not a device used to examine specimens derived from the human body to provide information for diagnosis, monitoring, or treatment.
- Device Description: The description clearly states it is a "neonatal incubator that provides a controlled environment." This aligns with a life support or environmental control device, not an IVD.
- No mention of biological specimens: There is no mention of analyzing blood, urine, tissue, or any other biological sample.
- No mention of diagnostic information: The device provides environmental control, not diagnostic information about the infant's health status based on biological samples.
Therefore, the Isolette® 8000 plus is a medical device, but it falls under a category other than In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The Isolette® 8000 plus is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
Product codes
FMZ
Device Description
The Isolette® 8000 plus is a neonatal incubator that provides a controlled environment for both premature and full-term infants up to a maximum of 10 kg (22lbs). It controls temperature, oxygen and humidity (both are optional).
The predicate device as cleared in K172154 is offered with the hood and shell assembly of the incubator mounted on a variable high adjustable (VHA) trolley. All components and accessories for the device were cleared as part of the system.
The modification of the device is the replacement of the variable height adjustable (VHA) trolley with a fixed-height cabinet stand trolley. All other components and accessories of the device are identical to those cleared under K172154.
The modification does not change the intended use or alter the fundamental scientific technology of the currently approved predicate device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
premature and full-term infants
Intended User / Care Setting
For use in any department of the hospital that provides neonatal and infant care, including NICU/Special Care Baby Unit and the Step Down Nursery, Newborn Nursery and pediatrics.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A risk analysis for the modification to the Isolette 8000 plus was performed according to ISO 14971 Application of Risk Management to Medical Devices and Draeger's standard operating procedure on Product Risk Management. A review of the Product Risk Management Report (PRMR) revealed there were no new hazards or risk control measures (RCMs) associated with the modification of the device.
The following identified verification and validation activities necessary to establish substantial equivalence to the predicate device were carried out under well established methods and their results are summarized within the Design Control Activities Summary table within this submission.
- Instability (mechanical) per IEC60601-1 ●
- Electrical Safety per IEC60601-1
- Electromagnetic Compatibility (EMC) per IEC60601-1-2 ●
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA). The HHS logo is on the left, and the FDA logo is on the right. The FDA logo includes the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
November 21, 2018
Draeger Medical Systems, Inc. Karen Otrupchak Project Manager, Regulatory Affairs 3135 Quarry Road Telford, Pennsylvania 18969
Re: K182977
Trade/Device Name: Isolette® 8000 Plus Regulation Number: 21 CFR 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: Class II Product Code: FMZ Dated: October 25, 2018 Received: October 26, 2018
Dear Karen Otrupchak:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Tina
Kiang-S
Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name Isolette® 8000 plus
Indications for Use (Describe)
The Isolette® 8000 plus is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22lbs).
The Isolette® 8000 plus is not intended for home use.
Type of Use (Select one or both, as applicable) | |
---|---|
Prescription Use (Part 21 CFR 801 Subpart D) | |
Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The word is centered in the image and takes up most of the space.
Special 510(k) Premarket Notification Summary K182977
| Submitter: | Draeger Medical Systems, Inc.
3135 Quarry Road
Telford, PA 18969 USA | |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------|
| Contact Person: | Karen Otrupchak
Project Manager, Regulatory Affairs
Email: karen.otrupchak@draeger.com
Phone: 215-660-2292
Fax: 215-721-5424 | |
| Date prepared: | 21 November 2018 | |
| Device Name: | Trade Name:
Classification Name:
Regulation Number:
Product Code:
Class: | Isolette® 8000 plus
Neonatal Incubator
21 CFR §880.5400
FMZ
II |
| Predicate Device: | Isolette® 8000 plus, K172154 | |
Draeger Medical Systems, Inc. is submitting a special 510(k) premarket notification for a modification to an existing device, the Isolette® 8000 Plus Neonatal Incubator, cleared under K172154.
Device Description
The Isolette® 8000 plus is a neonatal incubator that provides a controlled environment for both premature and full-term infants up to a maximum of 10 kg (22lbs). It controls temperature, oxygen and humidity (both are optional).
The predicate device as cleared in K172154 is offered with the hood and shell assembly of the incubator mounted on a variable high adjustable (VHA) trolley. All components and accessories for the device were cleared as part of the system.
The modification of the device is the replacement of the variable height adjustable (VHA) trolley with a fixed-height cabinet stand trolley. All other components and accessories of the device are identical to those cleared under K172154.
The modification does not change the intended use or alter the fundamental scientific technology of the currently approved predicate device.
Indications for Use
The Isolette® 8000 plus is indicated for thermoregulation and controlling oxygen (optional), and humidity (optional) for both premature and full-term infants up to a maximum of 10 kg (22 lbs). The Isolette® 8000 plus is not intended for home use.
4
Image /page/4/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The background is white.
Predicate Device | Modified Device | ||
---|---|---|---|
Specification | Isolette®8000 plus | Isolette®8000 plus (with cabinet stand) | Comments |
Manufacturer | Draeger Medical Systems, Inc. | Draeger Medical Systems, Inc. | N/A |
510(k) | K172154 | K182977 | N/A |
Regulation # | 880.5400 | Same | N/A |
Product Code | FMZ | Same | N/A |
Classification | II | Same | N/A |
UMDNS/GMDNS | |||
code | 12-113/36025 | Same | N/A |
Standards | 60601-1; 60601-1-2; 60601-2-19 | Same | N/A |
Part number | MU20602 | Same | N/A |
Model number | I8KP-1 | I8KP-1C | Different – Identifier for modified |
device | |||
Indications for Use | The Isolette® 8000 plus incubator is | ||
indicated for thermoregulation and | |||
controlling oxygen (optional), and | |||
humidity (optional) for both premature | |||
and full-term infants up to a maximum of | |||
10 kg (22 lbs). The Isolette® 8000 plus is | |||
not intended for home use. | Same | N/A | |
Target Population/ | |||
Patient Population | Newly born infants up to 10 kg. (22lbs) | Same | N/A |
Environment of | |||
Use | For use in any department of the hospital | ||
that provides neonatal and infant care, | |||
including NICU/Special Care Baby Unit | |||
and the Step Down Nursery, Newborn | |||
Nursery and pediatrics. | Same | N/A | |
System Specifications | |||
Principle of | |||
Operation | Controller-based incubator that enables | ||
simultaneous control of temperature, | |||
oxygen, and humidity parameters | |||
affecting the infant | Same | N/A | |
Protection class | Class I, Type BF, continuous operation, | ||
not AP | Same | N/A | |
Ingress of liquids | |||
and particulate | |||
matter IEC60601-1 | IPXO | Same | N/A |
Physical Attributes | |||
Height | 133.3 to 153.7 cm (52.5 to 60.5 in) | 140 cm ± 1.2 cm (55 in ± 0.5 in) | Different – No impact on effect on |
safety and effectiveness. | |||
Width | 38 x 74 x3 cm (15 x 29.1 x 1.2 in) | Same | N/A |
Trendelenburg/ | |||
Reverse Trendelenburg | Continuously variable to 12 deg. +1 deg. | Same | N/A |
Infant Weight | 10 kg (22 lbs.) maximum | Same | N/A |
Appearance | Variable Height Stand (VHA) with | ||
Isolette 8000 plus incubator mounted on | |||
top | Fixed Height / Cabinet Stand with Isolette | ||
8000 plus incubator mounted on top | Different – No impact on effect on | ||
safety and effectiveness. | |||
Mobility | Support stand able to raise and lower the | ||
incubator on VHA. Storage with swivel | |||
drawer storage. Three (3) dual total lock | |||
castors, one (1) dual steering castor | Support stand without the ability to raise | ||
and lower incubator. Storage ability | |||
permitted within cabinet stand. Four (4) | |||
Single castors with total lock function | Different – No impact on effect on | ||
safety and effectiveness. | |||
Power Routing and | |||
Convenience | |||
Outlets | Image: Incubator and VHA | Image: Incubator and Cab Stand | Different – Convenience outlet |
and actuator/electronics | |||
controlling the VHA removed. | |||
No impact on effect on safety | |||
and effectiveness. | |||
Environmental | |||
Operating | |||
temperature | Yes | Same | N/A |
Operating humidity | 5-95% RH non-condensing | Same | N/A |
Operating altitude | Up to 3000 m (9800 ft.) | Same | N/A |
Operating Ambient | |||
air pressure | 110-70 kPa | Same | N/A |
Storage temperature | -20 to 60 deg. C (-4 to 140 deg. F) | Same | N/A |
Storage humidity | 5-95% RH non-condensing | Same | N/A |
Storage Ambient | |||
air pressure | 110-50 kPa | Same | N/A |
Electrical Requirements | |||
Power req. | |||
100/120V | 100/120V, 50/60 Hz, 1900 W max, 9.9 A | ||
max | Same | N/A | |
Auxiliary power | |||
sockets | All 50/60 Hz | ||
100 V, 100W max | |||
120 & 230 V 300W max | Same | N/A | |
Earth Leakage | $≤$ 500 μΑ | Same | N/A |
General Performance | |||
Air temperature mode | |||
Set point range | 20 to 39 C (68-102.2 F) | Same | N/A |
Control override range | 37-39 C (98.6- 102.2 F) | Same | N/A |
Set point display range | 15 to 45 C (59-113 F) | Same | N/A |
Upwards deviation limit | +1.5 to +2.5 C (+2.7 to 4.5 F) | Same | N/A |
Upwards deviation limit default | +1.5 C (+2.7 F) | Same | N/A |
Downwards deviation limit range | -1.5 to -2.5C (-2.7 to -4.5F) | Same | N/A |
Downwards deviation limit default | -2.5C (-4.5F) | Same | N/A |
Warm-up time at 22C (72F) ambient | Kangaroo Mode | ||
Kangaroo Mode | Yes | Same | N/A |
Thermomonitoring | |||
Thermomonitoring | Yes | Same | N/A |
Misc. Specifications | |||
Noise level within the hood environment | 24 hours @ 85% RH and 37 deg. C, in air temp mode | Same | N/A |
Humidity control reservoir capacity | 1500 mL | Same | N/A |
Humidity control range | 30% to 95% in 1% increments (at high ambient humidity levels, low-level humidity settings may not be attainable) | Same | N/A |
Humidity control accuracy between 10% and 90% @ 20 to 40C (68 to 104F) | ±6% RH | Same | N/A |
Humidity display range | 10% to 100% | Same | N/A |
Maximum humidity levels | >85% (incubator set temp at 39C with at least 30% RH at ambient) | Same | N/A |
Oxygen control system (optional) | |||
Servo oxygen control system | Yes | Same | N/A |
Oxygen inlet pressure | 40 to 150 psi (2.8 kg/cm2 to 10.5 kg/cm2) | Same | N/A |
Oxygen inlet flow rate | 30 L/min | Same | N/A |
Oxygen control range | 21% to 65% | Same | N/A |
Oxygen display | 1% | Same | N/A |
resolution | |||
Oxygen display | ±3% | Same | N/A |
accuracy (100% | |||
calibration) | |||
Oxygen display | ±5% | Same | N/A |
accuracy (21% | |||
calibration) | |||
Oxygen display | 18% to 100% | Same | N/A |
range | |||
Oxygen control | ±2% of full scale | Same | N/A |
accuracy | |||
Manual oxygen control system (optional) | |||
Oxygen inlet | 40psi to 150 psi (2.8 kg/cm² to 10.5 | Same | N/A |
pressure | kg/cm²) | ||
Oxygen inlet flow | 30 L/min | Same | N/A |
rate | |||
Weighing System | |||
Standard weighing system (accessory) | |||
Weight display | 0 kg (0 lb.) to 7 kg (15.4 lbs.) | Same | N/A |
range | |||
Weight display | 1 g or 1oz | Same | N/A |
resolution | |||
Weight display | 0 to 2 kg: ±2 g (0 to 4.4 lb.: ±0.07 oz.) | Same | N/A |
accuracy | > 2 kg: ±5 g (>4.4 lb.: ±0. 18 oz.) | ||
Tare weight | ≤4.0 kg (8.82 lb.) | Same | N/A |
OIML weighing | Yes | Same | OIML weighing system is only for |
system (accessory) | EU countries requiring a scale that | ||
complies with the NAWI directive. | |||
Material - no implants | |||
Material used for | |||
indirect patient | |||
contact | Metal (e.g. Aluminum) Synthetic material | ||
(e.g. TPE, Thermoplastics) | Same | N/A | |
Material used for | |||
direct patient | |||
contact | Textile Polyurethane, TPE, Hydrogel | Same | N/A |
Biocompatibility | According to ISO 10993 | Same | N/A |
Components | |||
Hand ports | Yes | Same | N/A |
Iris ports | Yes | Same | N/A |
Access panel | Yes | Same | N/A |
Serial port | Yes | Same | N/A |
Skin temperature | |||
probes, probe | |||
covers | Yes | Same | N/A |
Oxygen, & air filter | |||
inlets | Yes | Same | N/A |
Sensor module | Yes | Same | N/A |
Hose grommets | Yes | Same | N/A |
Accessory rail | |||
and cable wrap | Yes | Same | N/A |
5
Image /page/5/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The background is white.
6
Image /page/6/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue.
Isolette 8000 plus Special 510(k) Comparison to Predicate
7
Image /page/7/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The background is white.
8
Image /page/8/Picture/0 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is a dark blue color. The "a" in Dräger has an umlaut above it, which is represented by two dots.
9
Image /page/9/Picture/0 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue and the background is white. The two dots above the "a" are also blue.
10
Image /page/10/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The background is white.
Isolette 8000 plus Special 510(k) Comparison to Predicate
11
Image /page/11/Picture/0 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is a dark blue color. The "a" in Dräger has an umlaut above it, which is represented by two dots.
12
Image /page/12/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The word is centered and takes up most of the image.
13
Image /page/13/Picture/0 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue. The word is centered in the image.
Discussion of Non-clinical Testing
The modification to the predicate device is the replacement of the variable height adjustable (VHA) trolley with a fixed-height cabinet stand. A risk analysis for the modification to the Isolette 8000 plus was performed according to ISO 14971 Application of Risk Management to Medical Devices and Draeger's standard operating procedure on Product Risk Management. A review of the Product Risk Management Report (PRMR) revealed there were no new hazards or risk control measures (RCMs) associated with the modification of the device.
The following identified verification and validation activities necessary to establish substantial equivalence to the predicate device were carried out under well established methods and their results are summarized within the Design Control Activities Summary table within this submission.
- Instability (mechanical) per IEC60601-1 ●
- Electrical Safety per IEC60601-1
- Electromagnetic Compatibility (EMC) per IEC60601-1-2 ●
Conclusion
Based on the intended use, technological characteristics, performance/non-clinical testing, and comparison to the predicate device, the modified device is substantially equivalent to the predicate device K172154 and does not raise different questions of safety and effectiveness than the predicate device.